US Stock MarketDetailed Quotes

CCCC C4 Therapeutics

Watchlist

6.640
+0.580+9.57%

Close Aug 23 16:00 ET

6.330
-0.310-4.67%

Post 20:02 ET

460.40MMarket Cap-3494P/E (TTM)

C4 Therapeutics Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual

YOY

Hide blank lines

(Q2)Jun 30, 2024

(Q1)Mar 31, 2024

(FY)Dec 31, 2023

(Q4)Dec 31, 2023

(Q3)Sep 30, 2023

(Q2)Jun 30, 2023

(Q1)Mar 31, 2023

(FY)Dec 31, 2022

(Q4)Dec 31, 2022

(Q3)Sep 30, 2022

Operating Cash Flow (Indirect Method)

Cash flow from continuing operating activities

73.82%-4.97M

45.30%-18.12M

-0.85%-106.84M

17.57%-24.01M

-9.59%-30.71M

14.41%-19M

-24.55%-33.13M

-21.82%-105.94M

-13.47%-29.13M

-52.63%-28.02M

Net income from continuing operations

50.68%-17.72M

18.46%-28.36M

-3.37%-132.49M

6.54%-34.75M

15.40%-27.04M

-31.04%-35.92M

-9.99%-34.78M

-52.79%-128.18M

-137.48%-37.19M

-29.47%-31.96M

Operating gains losses

----

--621K

--0

----

Depreciation and amortization

-2.18%448K

-17.80%448K

12.17%1.88M

-17.47%430K

7.71%447K

5.29%458K

78.69%545K

12.33%1.68M

61.30%521K

25.76%415K

Other non cash items

-2.01%1.71M

-13.74%1.49M

0.48%6.64M

-9.58%1.52M

-1.96%1.65M

-7.38%1.75M

26.84%1.73M

209.70%6.61M

173.78%1.68M

228.27%1.68M

Change In working capital

-37.41%5.87M

153.97%3.36M

58.65%-6.94M

615.61%3.4M

-220.72%-13.5M

265.40%9.38M

0.37%-6.22M

44.24%-16.78M

96.36%-660K

-262.13%-4.21M

-Change in receivables

2,586.20%12.43M

-290.37%-1.8M

-343.33%-10.33M

-75,433.33%-11.3M

137.84%528K

-893.65%-500K

-76.04%945K

444.48%4.24M

101.72%15K

-83.77%222K

-Change in prepaid assets

-127.91%-446K

-1,037.75%-4.67M

601.80%2.72M

671.35%1.32M

54.02%-692K

13.09%1.6M

61.17%498K

106.34%388K

103.42%171K

-2,567.21%-1.51M

-Change in payables and accrued expense

-252.60%-2.47M

-96.45%-7.48M

-9.20%1.59M

231.13%5.35M

-300.00%-1.57M

-62.13%1.62M

22.57%-3.81M

-45.28%1.75M

-44.18%1.62M

-40.75%785K

-Change in other current liabilities

-10.98%-1.3M

-11.74%-1.26M

-826.04%-4.7M

-11.46%-1.21M

-176.38%-1.19M

8.70%-1.18M

-469.74%-1.12M

42.91%-507K

-832.76%-1.08M

690.15%1.56M

-Change in other working capital

-129.95%-2.35M

779.71%18.56M

116.65%3.77M

769.49%9.24M

-100.68%-10.57M

177.40%7.84M

53.57%-2.73M

9.57%-22.65M

90.84%-1.38M

-44.25%-5.27M

Cash from discontinued investing activities

Operating cash flow

73.82%-4.97M

45.30%-18.12M

-0.85%-106.84M

17.57%-24.01M

-9.59%-30.71M

14.41%-19M

-24.55%-33.13M

-21.82%-105.94M

-13.47%-29.13M

-52.63%-28.02M

Investing cash flow

Cash flow from continuing investing activities

-177.28%-11.71M

-199.75%-53.4M

171.04%158.35M

244.09%31.95M

189.87%57.73M

-54.41%15.15M

1,436.94%53.53M

130.86%58.42M

115.63%9.28M

119.79%19.91M

Net PPE purchase and sale

45.58%-197K

--0

68.92%-1.71M

89.46%-157K

81.85%-600K

31.57%-362K

-242.44%-589K

-330.38%-5.5M

-1,266.97%-1.49M

---3.31M

Net investment purchase and sale

-174.20%-11.51M

-198.66%-53.4M

150.41%160.06M

197.96%32.1M

151.20%58.33M

-54.05%15.51M

1,512.32%54.12M

133.99%63.92M

118.17%10.77M

123.07%23.22M

Cash from discontinued investing activities

Investing cash flow

-177.28%-11.71M

-199.75%-53.4M

171.04%158.35M

244.09%31.95M

189.87%57.73M

-54.41%15.15M

1,436.94%53.53M

130.86%58.42M

115.63%9.28M

119.79%19.91M

Financing cash flow

Cash flow from continuing financing activities

118.10%135K

5,155.99%34.58M

3,865.91%45.49M

122,606.38%57.67M

-3,078.67%-10.75M

-388.03%-746K

-242.50%-684K

-99.33%1.15M

-89.91%47K

-38.18%361K

Net issuance payments of debt

--0

---12.5M

--0

---11M

---750K

--0

Net common stock issuance

--0

36,248.94%33.98M

--57.56M

--57.67M

---16K

--0

---94K

--0

Proceeds from stock option exercised by employees

6,650.00%135K

826.79%519K

-92.54%58K

--0

-99.23%2K

-78.46%56K

-66.65%777K

-93.75%47K

-75.83%211K

Net other financing activities

--0

-19.23%84K

-0.54%368K

---1K

75.33%263K

--2K

-52.73%104K

193.67%370K

--0

-16.67%150K

Cash from discontinued financing activities

Financing cash flow

118.10%135K

5,155.99%34.58M

3,865.91%45.49M

122,606.38%57.67M

-3,078.67%-10.75M

-388.03%-746K

-242.50%-684K

-99.33%1.15M

-89.91%47K

-38.18%361K

Net cash flow

Beginning cash position

76.48%93.1M

293.65%130.03M

-58.40%33.03M

21.95%64.43M

-20.50%48.16M

7.05%52.76M

-58.40%33.03M

-56.92%79.4M

-67.79%52.83M

-78.55%60.58M

Current changes in cash

-260.07%-16.55M

-287.26%-36.93M

309.19%97M

431.40%65.61M

310.01%16.27M

-140.69%-4.6M

165.48%19.72M

55.80%-46.37M

76.60%-19.8M

93.46%-7.75M

End cash Position

58.96%76.56M

76.48%93.1M

293.65%130.03M

21.95%64.43M

-20.50%48.16M

7.05%52.76M

-58.40%33.03M

-67.79%52.83M

Free cash flow

73.29%-5.17M

46.26%-18.12M

2.59%-108.55M

21.07%-24.17M

0.06%-31.31M

14.81%-19.36M

-25.95%-33.71M

-26.28%-111.44M

-18.77%-30.62M

-70.63%-31.33M

Currency Unit

USD

Accounting Standards

US-GAAP

Audit Opinions

Unqualified Opinion

	(Q2)Jun 30, 2024	(Q1)Mar 31, 2024	(FY)Dec 31, 2023	(Q4)Dec 31, 2023	(Q3)Sep 30, 2023	(Q2)Jun 30, 2023	(Q1)Mar 31, 2023	(FY)Dec 31, 2022	(Q4)Dec 31, 2022	(Q3)Sep 30, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities	73.82%-4.97M	45.30%-18.12M	-0.85%-106.84M	17.57%-24.01M	-9.59%-30.71M	14.41%-19M	-24.55%-33.13M	-21.82%-105.94M	-13.47%-29.13M	-52.63%-28.02M
Net income from continuing operations	50.68%-17.72M	18.46%-28.36M	-3.37%-132.49M	6.54%-34.75M	15.40%-27.04M	-31.04%-35.92M	-9.99%-34.78M	-52.79%-128.18M	-137.48%-37.19M	-29.47%-31.96M
Operating gains losses	----	----	--621K	--0	----	----	----	----	----	----
Depreciation and amortization	-2.18%448K	-17.80%448K	12.17%1.88M	-17.47%430K	7.71%447K	5.29%458K	78.69%545K	12.33%1.68M	61.30%521K	25.76%415K
Other non cash items	-2.01%1.71M	-13.74%1.49M	0.48%6.64M	-9.58%1.52M	-1.96%1.65M	-7.38%1.75M	26.84%1.73M	209.70%6.61M	173.78%1.68M	228.27%1.68M
Change In working capital	-37.41%5.87M	153.97%3.36M	58.65%-6.94M	615.61%3.4M	-220.72%-13.5M	265.40%9.38M	0.37%-6.22M	44.24%-16.78M	96.36%-660K	-262.13%-4.21M
-Change in receivables	2,586.20%12.43M	-290.37%-1.8M	-343.33%-10.33M	-75,433.33%-11.3M	137.84%528K	-893.65%-500K	-76.04%945K	444.48%4.24M	101.72%15K	-83.77%222K
-Change in prepaid assets	-127.91%-446K	-1,037.75%-4.67M	601.80%2.72M	671.35%1.32M	54.02%-692K	13.09%1.6M	61.17%498K	106.34%388K	103.42%171K	-2,567.21%-1.51M
-Change in payables and accrued expense	-252.60%-2.47M	-96.45%-7.48M	-9.20%1.59M	231.13%5.35M	-300.00%-1.57M	-62.13%1.62M	22.57%-3.81M	-45.28%1.75M	-44.18%1.62M	-40.75%785K
-Change in other current liabilities	-10.98%-1.3M	-11.74%-1.26M	-826.04%-4.7M	-11.46%-1.21M	-176.38%-1.19M	8.70%-1.18M	-469.74%-1.12M	42.91%-507K	-832.76%-1.08M	690.15%1.56M
-Change in other working capital	-129.95%-2.35M	779.71%18.56M	116.65%3.77M	769.49%9.24M	-100.68%-10.57M	177.40%7.84M	53.57%-2.73M	9.57%-22.65M	90.84%-1.38M	-44.25%-5.27M
Cash from discontinued investing activities
Operating cash flow	73.82%-4.97M	45.30%-18.12M	-0.85%-106.84M	17.57%-24.01M	-9.59%-30.71M	14.41%-19M	-24.55%-33.13M	-21.82%-105.94M	-13.47%-29.13M	-52.63%-28.02M
Investing cash flow
Cash flow from continuing investing activities	-177.28%-11.71M	-199.75%-53.4M	171.04%158.35M	244.09%31.95M	189.87%57.73M	-54.41%15.15M	1,436.94%53.53M	130.86%58.42M	115.63%9.28M	119.79%19.91M
Net PPE purchase and sale	45.58%-197K	--0	68.92%-1.71M	89.46%-157K	81.85%-600K	31.57%-362K	-242.44%-589K	-330.38%-5.5M	-1,266.97%-1.49M	---3.31M
Net investment purchase and sale	-174.20%-11.51M	-198.66%-53.4M	150.41%160.06M	197.96%32.1M	151.20%58.33M	-54.05%15.51M	1,512.32%54.12M	133.99%63.92M	118.17%10.77M	123.07%23.22M
Cash from discontinued investing activities
Investing cash flow	-177.28%-11.71M	-199.75%-53.4M	171.04%158.35M	244.09%31.95M	189.87%57.73M	-54.41%15.15M	1,436.94%53.53M	130.86%58.42M	115.63%9.28M	119.79%19.91M
Financing cash flow
Cash flow from continuing financing activities	118.10%135K	5,155.99%34.58M	3,865.91%45.49M	122,606.38%57.67M	-3,078.67%-10.75M	-388.03%-746K	-242.50%-684K	-99.33%1.15M	-89.91%47K	-38.18%361K
Net issuance payments of debt	--0	--0	---12.5M	--0	---11M	---750K	---750K	--0	--0	--0
Net common stock issuance	--0	36,248.94%33.98M	--57.56M	--57.67M	---16K	--0	---94K	--0	--0	--0
Proceeds from stock option exercised by employees	6,650.00%135K	826.79%519K	-92.54%58K	--0	--0	-99.23%2K	-78.46%56K	-66.65%777K	-93.75%47K	-75.83%211K
Net other financing activities	--0	-19.23%84K	-0.54%368K	---1K	75.33%263K	--2K	-52.73%104K	193.67%370K	--0	-16.67%150K
Cash from discontinued financing activities
Financing cash flow	118.10%135K	5,155.99%34.58M	3,865.91%45.49M	122,606.38%57.67M	-3,078.67%-10.75M	-388.03%-746K	-242.50%-684K	-99.33%1.15M	-89.91%47K	-38.18%361K
Net cash flow
Beginning cash position	76.48%93.1M	293.65%130.03M	-58.40%33.03M	21.95%64.43M	-20.50%48.16M	7.05%52.76M	-58.40%33.03M	-56.92%79.4M	-67.79%52.83M	-78.55%60.58M
Current changes in cash	-260.07%-16.55M	-287.26%-36.93M	309.19%97M	431.40%65.61M	310.01%16.27M	-140.69%-4.6M	165.48%19.72M	55.80%-46.37M	76.60%-19.8M	93.46%-7.75M
End cash Position	58.96%76.56M	76.48%93.1M	293.65%130.03M	293.65%130.03M	21.95%64.43M	-20.50%48.16M	7.05%52.76M	-58.40%33.03M	-58.40%33.03M	-67.79%52.83M
Free cash flow	73.29%-5.17M	46.26%-18.12M	2.59%-108.55M	21.07%-24.17M	0.06%-31.31M	14.81%-19.36M	-25.95%-33.71M	-26.28%-111.44M	-18.77%-30.62M	-70.63%-31.33M
Currency Unit	USD	USD	USD	USD	USD	USD	USD	USD	USD	USD
Accounting Standards	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP
Audit Opinions	--	--	--	--	--	--	--	Unqualified Opinion	--	--

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List

Overall